Beneficient (BENF) AI Stock Analysis

Beneficient is a Dallas, Texas-based technology-driven financial services provider that delivers liquidity solutions within the alternative asset industry. The company operates the AltAccess platform, a comprehensive ecosystem featuring AltLiquidity for online liquidity discovery with cyber-security protections, AltQuote for real-time asset quoting, AltCustody for digital tracking and management, AltData for investment analytics, and AltTrading for transaction execution. Beneficient serves a client base that includes mid-to-high net worth individuals, small-to-midsize institutional investors, family offices, and fund general partners seeking streamlined liquidity and data insights.

Beneficient generated revenue of $47.9M in FY2022 before recording negative revenue of -$105.0M in FY2023, -$98.9M in FY2024, -$7.9M in FY2025, and -$39.1M in FY2026. Annual net income moved from -$95.0M in FY2022 and -$131.0M in FY2023 to -$2.10B in FY2024, before reaching $51.2M in FY2025 and returning to -$87.4M in FY2026. FY2026 gross margin stood at 2.2% with an operating margin of 203.9% and an EPS of -$5.37. For the trailing twelve months ending June 30, 2026, revenue was -$14.3M with quarterly revenue growth of 73.4% year-over-year.

As of June 30, 2026, Beneficient held $5.6M in cash and short-term investments against total debt of $96.8M, yielding net debt of $91.2M. Shareholders' equity stood at $90.5M out of total assets of $250.9M. The company recorded a current ratio of 0.09 and a debt-to-equity ratio of 1.07. For FY2026, free cash flow was -$38.8M with operating cash flow of -$38.7M and capital expenditures of $96,000, while its share count changed by 2020.1% over 5 years.

Beneficient trades at a market capitalization of $16.3M and an enterprise value of $133.6M. Its forward P/E of 6.9x is lower than the 10.8x median of its US-listed Financial Services peers. The stock has a price-to-sales ratio of 0.1x and an EV-to-EBITDA ratio of 8.0x, compared to sector peer medians of 3.2x and 11.7x, respectively. Over the past year, BENF shares fell 76.0%, significantly lagging the S&P 500 benchmark SPY return of 16.8%. The stock also trades 68.0% below its 200-day average.

Beneficient has a mean price target of $9.00, representing a potential upside of 757.1% above its last close of $1.05. For the fiscal year ending March 31, 2027, the consensus estimate projects revenue of $59.5M and an EPS of -$2.60. For the next fiscal year, 1 analyst projects revenue of $0 and an EPS of $0.01. Beneficient beat EPS estimates in 2 of the last 4 quarters, with its next earnings report scheduled for November 13, 2026.

This page is an AI-written research summary of Beneficient (BENF). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: BENF income statement, BENF balance sheet, BENF key metrics, BENF analyst forecast, BENF chart. See the BENF stock overview for the latest quote and news.